|
The SMi Group’s 3rd Annual Optimising Drug Formulation Conference aims to explore the key role of formulation throughout pharmaceutical development. Solubility continues to remain a fundamental challenge for the industry and will be addressed with a targeted session.
A special focus will also be placed on the unique challenges in Biopharmaceutical drug formulation, as innovations of today will prove to be the next decade’s blockbusters. With formulation playing such a key role in the makings of a successful product, partnership sourcing and management of collaborations will be explored in dedicated case-study presentations.
The conference aims to bring two days of superb case study presentations, exploring current research and development in the formulation field. Confirmed Speakers Include: - Dr Tomas Landh, Principal Scientist, Preformulation and Delivery, Novo Nordisk
- Dr Barbara Lueckel, Global Drug Delivery Evaluator, Roche
- Dr Thomas Backensfeld, Head, Global Pharmaceutical Development, Bayer Schering Pharma
- Dr Ingvar Ymén, Principal Scientist, Analytical Chemistry, AstraZeneca
- Dr David Cipolla, Director, Pharmaceutical Sciences, Aradigm
- Kevin Maynard, Development Director, Imprint Pharmaceuticals
- Dr Alyson Connor, Principal Scientist, Pharmaceutical Profiles
- Annabel Boardman, Market Development Manager, Colorcon
This successful annual event attracts Executives, Directors and Scientists working in the pharmaceutical and biotech industries within: - Drug Formulation - Research and Development
- Drug Delivery
- Business Development and Strategic Licensing
- Technology Development
|
Events Home Page
